Citius Pharmaceuticals Stock Price - CTXR

0.0779 (8.64%)
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Citius Pharmaceuticals Inc CTXR NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 0.9021 0.00 0.00 0.00 0.9021 05:35:27
Bid Price Ask Price Spread Spread % News
0.9651 0.98 0.0149 1.52% - -
Stock Trades Traded Volume Average Volume 52 Week Range
11 2,236 1,663,110 0.40 - 1.50
Last Trade Time Type Quantity Stock Price Currency
05:59:19 formt 100 $ 0.98 USD

Citius Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 40.76M 45.19M 32.88M $ - $ - -0.78 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 32.30%

more financials information »

Citius Pharmaceuticals News

Date Time Source News Article
6/02/202016:33Edgar (US Regulatory)Current Report Filing (8-k)
6/02/202009:30PR Newswire (US)Citius Receives Positive FDA Feedback on Its Submitted Plan..
5/26/202016:16Edgar (US Regulatory)Current Report Filing (8-k)
5/26/202008:15PR Newswire (US)Citius Announces Expanded Access Program for Investigational..
5/19/202011:45Edgar (US Regulatory)Small Company Offering and Sale of Securities Without..
5/18/202016:11Edgar (US Regulatory)Current Report Filing (8-k)
5/18/202014:30PR Newswire (US)Citius Announces Closing of $7.5 Million Registered Direct..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CTXR Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.870.9850.83010.89728321,889,2950.03213.69%
1 Month0.88651.240.770.88912461,860,5400.01561.76%
3 Months0.61111.300.4150.82765581,350,2910.29147.62%
6 Months0.441.450.400.8686662961,4930.4621105.02%
1 Year1.191.500.400.8663516543,162-0.2879-24.19%
3 Years3.405.490.401.18265,335-2.50-73.47%
5 Years3.405.490.401.18265,335-2.50-73.47%

Citius Pharmaceuticals Description

Citius Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the development and commercialization of anti-infective products, adjunctive cancer care, and unique prescription products. Citius is currently advancing two proprietary product candidates, Mino-Lok product and a Hydrocortisone-Lidocaine formulation. Mino-Lok product is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections. The company's Hydrocortisone-Lidocaine provides anti-inflammatory and anesthetic relief to patients suffering from Grade I and II hemorrhoids. It is primarily operating within the critical care and cancer care market segments.
Your Recent History
Citius Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200603 10:18:29